{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pharmacogenomics of Cytochrome P450 of Nimodipine Metabolism after Aneurysmal Subarachnoid Hemorrhage

Activity Steps

Purpose of Activity

To discuss the pathophysiology and treatment of subarachnoid hemorrhage, including a review of the cytochrome P450 enzyme system and how it affects nimodipine therapy for patients with subarachnoid hemorrhage.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Review the risk factors, manifestations, outcomes, and diagnosis of subarachnoid hemorrhage.
  2. Summarize the pharmacotherapy and pharmacogenomics of nimodipine for patients with subarachnoid hemorrhage.
Price: $17.95


  • ANCC 1.5 CH / 0.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: JNN0919
Published: Oct 2019
Expires: 9/3/2021
Required Passing Score: 13/18 (72%)
Authors: Sarah H. Peacock, DNP, APRN; Courtney James, MD; Marion T. Turnbull, PhD; Jennifer B. Cowart, MD; Joel M. Reid, PhD; W. David Freeman, MD